Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Pablo Cagnoni [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Pablo Cagnoni, our President and Global Head of Research and Development, adopted a trading plan on April 30, 2026 providing for the sale of up to an aggregate of 139,381 shares of our common stock until May 1, 2028.
|
| Name | Pablo Cagnoni |
| Title | President and Global Head of Research and Development, |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | April 30, 2026 |
| Expiration Date | May 1, 2028 |
| Arrangement Duration | 732 days |
| Aggregate Available | 139,381 |
| Patrick Mayes [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Patrick Mayes, our Executive Vice President, Chief Scientific Officer, adopted a trading plan on April 29, 2026 providing for the sale of up to an aggregate of 52,131 shares of our common stock until April 29, 2027.
|
| Name | Patrick Mayes |
| Title | Executive Vice President, Chief Scientific Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | April 29, 2026 |
| Expiration Date | April 29, 2027 |
| Arrangement Duration | 365 days |
| Aggregate Available | 52,131 |